Deposition of amyloid β in the walls of human leptomeningeal arteries in relation to perivascular drainage pathways in cerebral amyloid angiopathy

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1862, Issue 5, 2016, Pages 1037-1046

  Keable, Abby ^a   Fenna, Kate ^a   Yuen, Ho Ming ^a   Johnston, David A ^a   Smyth, Neil R ^a   Smith, Colin ^b   Salman, Rustam Al Shahi ^b   Samarasekera, Neshika ^b   Nicoll, James A R ^a   Attems, Johannes ^c   Kalaria, Rajesh N ^c   Weller, Roy O ^a   Carare, Roxana O ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Amyloid ; Basement membranes; Cerebral amyloid angiopathy; Leptomeningeal arteries; Perivascular drainage

Indexed keywords

AMYLOID BETA PROTEIN; COLLAGEN TYPE 4; ENTACTIN; FIBRONECTIN; NIDOGEN 2; SMOOTH MUSCLE ACTIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTERY WALL; ARTICLE; BASEMENT MEMBRANE; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONNECTIVE TISSUE; CONTROLLED STUDY; FEMALE; GRAY MATTER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEPTOMENINGEAL ARTERY; MALE; MEMBRANE COMPONENT; MENINGEAL ARTERY; MIDDLE AGED; OCCIPITAL CORTEX; PARENCHYMA; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; TUNICA MEDIA; VASCULAR AMYLOIDOSIS; VERY ELDERLY; WHITE MATTER; YOUNG ADULT;

EID: 84949940505     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2015.08.024     Document Type: Article

References (43)

1. Thal D.R., von Arnim C., Griffin W.S., Yamaguchi H., Mrak R.E., Attems J., et al. Pathology of clinical and preclinical Alzheimer's disease. Eur. Arch. Psychiatry Clin. Neurosci. 2013, 263(Suppl 2):S137-S145.
2. Weller R.O., Yow H.Y., Preston S.D., Mazanti I., Nicoll J.A. Cerebrovascular disease is a major factor in the failure of elimination of Abeta from the aging human brain: implications for therapy of Alzheimer's disease. Ann. NY Acad. Sci. 2002, 977:162-168.
3. Preston S.D., Steart P.V., Wilkinson A., Nicoll J.A., Weller R.O. Capillary and arterial cerebral amyloid angiopathy in Alzheimer's disease: defining the perivascular route for the elimination of amyloid beta from the human brain. Neuropathol. Appl. Neurobiol. 2003, 29(2):106-117.
4. Attems J., Jellinger K. Neuropathological correlates of cerebral multimorbidity. Curr. Alzheimer Res. 2013, 10(6):569-577.
5. Kalaria R.N. Cerebrovascular disease and mechanisms of cognitive impairment: evidence from clinicopathological studies in humans. Stroke; J Cereb. Circ. 2012, 43(9):2526-2534.
6. Carare R.O., Hawkes C.A., Jeffrey M., Kalaria R.N., Weller R.O. Cerebral amyloid angiopathy, prion angiopathy, CADASIL and the spectrum of protein elimination-failure angiopathies (PEFA) in neurodegenerative disease with a focus on therapy. Neuropathol. Appl. Neurobiol. 2013.
7. Viswanathan A., Greenberg S.M. Cerebral Amyloid Angiopathy in the Elderly. Ann. Neurol. 2011, 79:871-880.
8. McCarron M.O., Nicoll J.A., Ironside J.W., Love S., Alberts M.J., Bone I. Cerebral amyloid angiopathy-related hemorrhage. Interaction of APOE epsilon2 with putative clinical risk factors 60. Stroke; J Cereb. Circ. 1999, 30(8):1643-1646.
9. Nicoll J.A., Yamada M., Frackowiak J., Mazur-Kolecka B., Weller R.O. Cerebral amyloid angiopathy plays a direct role in the pathogenesis of Alzheimer's disease. Pro-CAA position statement. Neurobiol. Aging 2004, 25(5):589-597.
10. Charidimou A., Meegahage R., Fox Z., Peeters A., Vandermeeren Y., Laloux P., et al. Enlarged perivascular spaces as a marker of underlying arteriopathy in intracerebral haemorrhage: a multicentre MRI cohort study. J. Neurol. Neurosurg. Psychiatry 2013, 84(6):624-629.
11. Thal D.R., Walter J., Saido T.C., Fandrich M. Neuropathology and biochemistry of Abeta and its aggregates in Alzheimer's disease. Acta Neuropathol. 2015, 129(2):167-182.
12. Love S., Chalmers K., Ince P., Esiri M., Attems J., Jellinger K., et al. Development, appraisal, validation and implementation of a consensus protocol for the assessment of cerebral amyloid angiopathy in post-mortem brain tissue. Am. J. Neurodegenerative Dis. 2014, 3(1):19-32.
13. Charidimou A., Fox Z., Werring D.J., Song M. Mapping the landscape of cerebral amyloid angiopathy research: an informetric analysis perspective. J. Neurol. Neurosurg. Psychiatry 2015.
14. Carare R.O., Bernardes-Silva M., Newman T.A., Page A.M., Nicoll J.A., Perry V.H., et al. Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunology. Neuropathol. Appl. Neurobiol. 2008, 34(2):131-144.
15. Hawkes C.A., Hartig W., Kacza J., Schliebs R., Weller R.O., Nicoll J.A., et al. Perivascular drainage of solutes is impaired in the ageing mouse brain and in the presence of cerebral amyloid angiopathy. Acta Neuropathol. 2011, 121(4):431-443.
16. Hawkes CA, Sullivan PM, Hands S, Weller RO, Nicoll JA, Carare RO. Disruption of arterial perivascular drainage of amyloid-beta from the brains of mice expressing the human APOE epsilon4 allele. PLoS One . 2012;7(7):e41636.
17. Hawkes C.A., Gatherer M., Sharp M.M., Dorr A., Yuen H.M., Kalaria R., et al. Regional differences in the morphological and functional effects of aging on cerebral basement membranes and perivascular drainage of amyloid-beta from the mouse brain. Aging Cell 2013, 12(2):224-236.
18. Hawkes C.A., Jayakody N., Johnston D.A., Bechmann I., Carare R.O. Failure of perivascular drainage of beta-amyloid in cerebral amyloid angiopathy. Brain Pathol. 2014, 24(4):396-403.
19. Roberts K.F., Elbert D.L., Kasten T.P., Patterson B.W., Sigurdson W.C., Connors R.E., et al. Amyloid-beta efflux from the central nervous system into the plasma. Ann. Neurol. 2014, 76(6):837-844.
20. Maki T., Okamoto Y., Carare R.O., Hase Y., Hattori Y., Hawkes C.A., et al. Phosphodiesterase III inhibitor promotes drainage of cerebrovascular beta-amyloid. Ann. Clin. Transl. Neurol. 2014, 1(8):519-533.
21. Carare R.O., Hawkes C.A., Jeffrey M., Kalaria R.N., Weller R.O. Review: cerebral amyloid angiopathy, prion angiopathy, CADASIL and the spectrum of protein elimination failure angiopathies (PEFA) in neurodegenerative disease with a focus on therapy. Neuropathol. Appl. Neurobiol. 2013, 39(6):593-611.
22. Braak H., Alafuzoff I., Arzberger T., Kretzschmar H., Del Tredici K. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol. 2006, 112(4):389-404.
23. Thal D.R., Rub U., Orantes M., Braak H. Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 2002, 58(12):1791-1800.
24. Mirra S.S., Heyman A., McKeel D., Sumi S.M., Crain B.J., Brownlee L.M., et al. The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991, 41(4):479-486.
25. Montine T., Phelps C., Beach T., Bigio E., Cairns N., Dickson D., et al. National institute on aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. Acta Neuropathol. 2012, (123):1-11.
26. McKeith I.G., Dickson D.W., Lowe J., Emre M., O'Brien J.T., Feldman H., et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005, 65(12):1863-1872.
27. Attems J., Jellinger K., Thal D.R., Van Nostrand W. Sporadic cerebral amyloid angiopathy. Neuropathol. Appl. Neurobiol. 2011, 37:75-93.
28. Kiuchi Y., Isobe Y., Fukushima K. Entactin-induced inhibition of human amyloid beta-protein fibril formation in vitro. Neurosci. Lett. 2001, 305(2):119-122.
29. Frackowiak J., Zoltowska A., Wisniewski H.M. Non-fibrillar beta-amyloid protein is associated with smooth muscle cells of vessel walls in Alzheimer disease. J. Neuropathol. Exp. Neurol. 1994, 53(6):637-645.
30. Wisniewski H.M., Wegiel J. Beta-amyloid formation by myocytes of leptomeningeal vessels. Acta Neuropathol. 1994, 87(3):233-241.
31. Calhoun M.E., Burgermeister P., Phinney A.L., Stalder M., Tolnay M., Wiederhold K.H., et al. Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid. Proc. Natl. Acad. Sci. U. S. A. 1999, 96(24):14088-14093.
32. Herzig M.C., Van Nostrand W.E., Jucker M. Mechanism of cerebral beta-amyloid angiopathy: murine and cellular models. Brain Pathol. 2006, 16(1):40-54.
33. Deane R., Wu Z., Sagare A., Davis J., Du Yan S., Hamm K., et al. LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms. Neuron 2004, 43(3):333-344.
34. Shirotani K., Tsubuki S., Iwata N., Takaki Y., Harigaya W., Maruyama K., et al. Neprilysin degrades both amyloid beta peptides 1-40 and 1-42 most rapidly and efficiently among thiorphan- and phosphoramidon-sensitive endopeptidases 98. J. Biol. Chem. 2001, 276(24):21895-21901.
35. Iliff J.J., Wang M., Zeppenfeld D.M., Venkataraman A., Plog B.A., Liao Y., et al. Cerebral arterial pulsation drives paravascular CSF-interstitial fluid exchange in the murine brain. J. Neurosci. Off. J. Soc. Neurosci. 2013, 33(46):18190-18199.
36. Yasojima K., Akiyama H., McGeer E.G., McGeer P.L. Reduced neprilysin in high plaque areas of Alzheimer brain: a possible relationship to deficient degradation of beta-amyloid peptide 2. Neurosci. Lett. 2001, 297(2):97-100.
37. Miners J.S., Baig S., Palmer J., Palmer L.E., Kehoe P.G., Love S. Abeta-degrading enzymes in Alzheimer's disease. Brain Pathol. 2008, 18(2):240-252.
38. Iliff J.J., Wang M., Liao Y., Plogg B.A., Peng W., Gundersen G.A., et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta. Sci. Transl. Med. 2012, 4(147). 147ra11.
39. Schley D., Carare-Nnadi R., Please C.P., Perry V.H., Weller R.O. Mechanisms to explain the reverse perivascular transport of solutes out of the brain. J. Theor. Biol. 2006, 238(4):962-974.
40. Weller R.O., Boche D., Nicoll J.A. Microvasculature changes and cerebral amyloid angiopathy in Alzheimer's disease and their potential impact on therapy. Acta Neuropathol. 2009, 118(1):87-102.
41. Liu A.K., Chang R.C., Pearce R.K., Gentleman S.M. Nucleus basalis of Meynert revisited: anatomy, history and differential involvement in Alzheimer's and Parkinson's disease. Acta Neuropathol. 2015, 129(4):527-540.
42. Weller R.O., Hawkes C.A., Carare R.O., Hardy J. Does the difference between PART and Alzheimer's disease lie in the age-related changes in cerebral arteries that trigger the accumulation of Abeta and propagation of tau?. Acta Neuropathol. 2015.
43. Rosand J., Muzikansky A., Kumar A., Wisco J.J., Smith E.E., Betensky R.A., et al. Spatial clustering of hemorrhages in probable cerebral amyloid angiopathy. Ann. Neurol. 2005, 58(3):459-462.